12/17/2021Recent Executive Moves

12/16/2021US Sanctions Chinese Painkiller Makers Amid Addiction Epidemic, As Sen...

12/16/2021Zai Lab's NUZYRA Approved in China as a Class 1 New Drug for CABP and ...

12/16/2021US Sanctions Chinese Tech Firms/Institutes for Weaponizing Biotech, Sp...

12/15/2021China Biopharma, Tech Stocks Fall on Reports of Expanded U.S. Sanction...

12/15/2021New Study: China Healthcare under Remaking in Digital Era

12/15/2021Chinese Telemedicine Stocks Feel the Pain as Tougher Rules Loom (WSJ)

12/14/2021Antengene Enters Clinical Collaboration with BMS to Evaluate ATG-017 i...

12/14/2021China Issues the Provisions for National Pharmaceutical Reserve (2021 ...

12/13/2021IQVIA: Chinese Hospital Drug Market Growth Slowed to 2.7% in Q3/2021

12/13/2021Universe and Kitanihon Enter Strategic Deal with Plan for Kampo Man...

12/13/2021Biosion Licenses Worldwide Rights of Anti-TROP-2 mAb BSI04702 to OBI P...

12/13/2021CDE: Annual Report on Clinical Trials for New Drug Registration in Chi...

12/13/2021China's NRDL Explained: 67 New Drugs, 62% Price Cut, 80% Success Rate ...

12/13/2021Nine Observations from A Busy Few Weeks Back at the Heart of the China...

12/10/2021Recent Executive Moves

12/9/2021Hoth Therapeutics Sign API and Drug Product Contracts with WuXi STA to...

12/9/2021Simcere Pharma and Immunophage Gain Three New Drug IND Approvals in Ch...

12/9/2021China Extends Crackdown of BMI Frauds for Another Year

12/8/2021CDE Issues the Technical Guidelines for Application of Biomarkers in C...

12/8/2021Shanghai Pharma and Syntegon Partner to Promote Continuous Manufacturi...

12/7/2021Sanofi Scores A Trademark Win in China

12/6/2021Ji Xing Completes P1 Study of Aficamten, A Potential Next-Gen Cardiac...

12/6/2021Junshi Granted Chinese sNDA Approval for Toripalimab in Combo with Cis...

12/6/2021Rhythm Enters Licensing Deal with RareStone to Commercialize Rare Obes...

12/6/2021SoftBank Reportedly in Investment Talks with Chinese mRNA Vaccine Firm...

12/6/2021Fujifilm Irvine Scientific Establishes Innovation Center in China

12/6/2021Chinese Official A 'Hero' After Forcing Biogen to Cut Cost of Treatmen...

12/6/2021Maximizing China Access for Innovative Therapies (PharmExec)

12/5/2021Biogen's Spinraza, Fosun-Kite's Yescarta and A Controversial Alzheimer...

Page:79/360 Total number of articles:10791: [First][<<] [77] [78] [79] [80] [81] [>>] [End]